Interleukin-13 receptor chain: A novel tumor-associated transmembrane protein in primary explants of human malignant gliomas

Cancer Research

Volumn 60, Issue 5, 2000, Pages 1168-1172

  Joshi, Bharat H ^b   Plautz, Gregory E ^c   Puri, Raj K ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13 RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; TUMOR ANTIGEN;

ARTICLE; BRAIN CELL; BRAIN TUMOR; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; GENE EXPRESSION; GLIOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

ADULT; AGED; BRAIN NEOPLASMS; GLIOMA; HUMANS; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; MIDDLE AGED; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0034162718     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Levin, V. A., Sheline. G. H., and Gutin, P. H. Neoplasm of the central nervous system. In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Cancer Principles and Practice of Oncology, Ed. 3, pp. 1557-1611. Philadelphia: J. B. Lippincott Company, 1989.
2. Huhn, S. L., Mohapatra, G., Bollen, A., Lamnorn, K., Prados, M. D., and Feuerstein, B. G. Chromosomal abnormalities in glioblastoma multiforme by comparative genomic hybridization: correlation with radiation treatment outcome. Clin. Cancer Res., 5: 1435-1443, 1999.
3. Jin, W., Bi, W., Huang, E. S-C., and Cote, G. J. Glioblastoma cell-specific expression of fibroblast growth factor receptor-1b requires an intronic represser of RNA splicing. Cancer Res., 59: 316-319. 1999.
4. Kurpad, S. N., Zhao, X. G., Wikstrand, C. J., Batra, S. K., Mclendon, R. E., and Bigner, D. D. Tumor-antigen in astrocytic gliomas. Glia, 15: 244-256, 1995.
5. Laske, D. W., Youle, R. J., and Oldfield, E. H. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat. Med., 3: 1362-1368, 1997.
6. Puri, R. K., Leland, P., Kreitman, R. J., and Pastan, I. Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL-4 Pseudomonas exotoxin chimeric protein. Int. J. Cancer, 58: 574-581, 1994.
7. Puri, R. K., Hoon, D. S., Leland, P., Snoy, P., Rand, R. W., Pastan, I., and Kreitman, R. J. Preclinical development of a recombinant toxin containing circularly permutated interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma. Cancer Res., 56, 5631-5631, 1996.
8. Debinski, W., Obiri, N. I., Powers, S. K., Pastan, I., and Puri, R. K. Human glioma cells over-express receptor for IL-13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 Pseudomonas exotoxin. Clin. Cancer Res., I: 1253-1258, 1995.
9. Debinski, W., Miner, R., Leland, P., Obiri, N. I., and Puri, R. K. Receptor for IL-13 does not interact with IL-4 but receptor for IL-4 interact with IL-13 on human glioma cells. J. Biol. Chem., 271: 22428-22433, 1996.
10. Debinski, W., Hulet, S., Connor, J., Powers, S. K., Gillespie, G. Y., and Puri, R. K. Overexpression of a receptor for interleukin 13 in human glioblastoma multiforme detected in situ. In: Second Annual Scientific Meeting of Society for Neuro-Oncology, p. 31. Charlottesville, VA: Society for Neuro-Oncology, 1997.
11. Murata, T., Noguchi, P. D., and Puri, R. K. Receptors for interleukin (IL-4) do not associate with the common j chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells. J. Biol. Chem., 270: 30829-30836, 1995.
12. Murata. T., Obiri, N. I., and Puri, R. K. Structure of and signal transduction through interleukin-4 and interleukin-13 receptors. Int. J. Mol. Med., 1: 551-557, 1998.
13. Murata, T., Obiri, N. I, Debinski, W., and Puri, R. K. Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells. Biochem. Biophys. Res. Commun., 238: 90-94, 1997.
14. Murata, T., Obiri, N. I., and Puri, R. K. Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: comparison between IL-4 and IL-13-induced signal transduction. Int. J. Cancer, 70: 230-240, 1997.
15. Obiri, N. I., Leland, P., Murata, T., Debinski, W., and Puri, R. K. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. J. Immunol., 158: 756-764, 1997.
16. Murata, T., Husain, S. R., Mohri, H., and Puri, R. K. Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway. Int. Immunol., 10: 1103-1110, 1998.
17. Obiri, N. I., Debinski, W., Leonard, W., and Puri, R. K. Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common γ chain shared by receptors for interleukins 2, 4, 7, 9 and 15. J. Biol. Chem., 270: 8797-8804, 1997.
18. Obiri, N. I., Murata, T., Debinski, W., and Puri, R. K. Modulation of interleukin (IL)-13 binding and signaling by the gc chain of the IL-2 receptor. J. Biol. Chem., 272: 20251-20258, 1997.
19. Kuznetsov, V. A., and Puri, R. K. Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor y chain. Biophys. J., 77: 154-172, 1999.
20. Zhang, Jian-Guo, Hilton, D. J., Wilson, T. A., McFarlane, C., Roberts, B. A., Moritz, R. L., Simpson, R. J., Alexander, W. S., Metcalf, D., and Nicola, N. A. Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. J. Biol. Chem., 14: 9474-9480, 1997.
21. Martell, L. A., Agrawal, A., Ross, D. A., and Muraszko, K. M. Efficacy of transferrin receptor-targeted immunotoxin in brain tumor cell lines and pediatric brain tumors. Cancer Res., 53: 1348-1353, 1993.
22. Lemaistre, C. E., Meneghetti, C., Howes, L., and Osborne, C. K., Targeting the EGF receptor in breast-cancer-treatment. Breast Cancer Res. Treat., 32: 97-103, 1994.
23. DiMassimo, A. M., DiLoreto, M., Pacilli, A., Raucci, G., Dalatri, L., Mele, A., Bolognesi, A., Polito, L., Stirpe, F., and DeSantis, R. Immunoconjugates made from an anti-EGF receptor monoclonal antibody and type 1 ribosome-inactivating proteins from Saponaria ocymoides or Vaccaria pyramidata. Br. J. Cancer, 75: 822-828, 1997.
24. Husain, S. R., Obiri, N. I., Gill, P., Zheng, T., Pastan, I., Debinski, W., and Puri, R. K. Receptor for interleukin 13 on AIDS associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin based chimeric toxin protein. Clin. Cancer Res., 3: 151-156, 1997.
25. Puri, R. K., Leland, P., Obiri, N. I., Husain, S. R., Kieitman, R. J., Hass, G. P., Pastan, I., and Debinski, W. Targeting of IL-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR). Blood, 87: 4333-4339, 1996.
26. Debinski, W., Gibo, D. M., Obiri, N. I., Kealiher, A., and Puri, R. K. Novel anti-tumor cytotoxins specific for cancer cells. Nat. Biotechnol., 16: 449-453, 1998.